. | Thermal energy . | Non-thermal energy . | |
---|---|---|---|
CBA . | RFA . | PFA . | |
Mechanism | Freezing | Heating | Electric current generation |
Characteristics | Thermal cell damage | Thermal cell damage | Non-thermal cell damage |
Tissue selectivity | Nonselective | Nonselective | Selective |
Catheters footprint | Balloon | Balloon & Point-by-point | Different footprints |
Time to ablation effect | Time-needed thermal effect | Time-needed thermal effect | Instant electroporation |
Patient preparation | Deep sedation or GA | Deep sedation or GA | Deep sedation or GA |
Fluoroscopy | Majority needed | Majority needed | Needed |
3-D mapping integration | No | Yes | With or without |
First pass PVI | > 98% | 98% | ~100% |
Ablation time | ++ | ++ | + |
Single-shot isolation | + | + | ++ |
Ablation beyond PVs | No | Yes | Possible |
Adjacent tissue damage* | Yes | Yes | No |
Pericardial injury | Rare | + | No |
Esophageal fistula | No | + | No |
Phrenic nerve palsy | + (usually transient) | Rare | No |
Coronary artery injury | No | Possible | + (spasm with pentaspline) |
Hemolysis | No | No | Possible |
Durability at 1 year | 60–73% | 70–90% | 70–90% |
. | Thermal energy . | Non-thermal energy . | |
---|---|---|---|
CBA . | RFA . | PFA . | |
Mechanism | Freezing | Heating | Electric current generation |
Characteristics | Thermal cell damage | Thermal cell damage | Non-thermal cell damage |
Tissue selectivity | Nonselective | Nonselective | Selective |
Catheters footprint | Balloon | Balloon & Point-by-point | Different footprints |
Time to ablation effect | Time-needed thermal effect | Time-needed thermal effect | Instant electroporation |
Patient preparation | Deep sedation or GA | Deep sedation or GA | Deep sedation or GA |
Fluoroscopy | Majority needed | Majority needed | Needed |
3-D mapping integration | No | Yes | With or without |
First pass PVI | > 98% | 98% | ~100% |
Ablation time | ++ | ++ | + |
Single-shot isolation | + | + | ++ |
Ablation beyond PVs | No | Yes | Possible |
Adjacent tissue damage* | Yes | Yes | No |
Pericardial injury | Rare | + | No |
Esophageal fistula | No | + | No |
Phrenic nerve palsy | + (usually transient) | Rare | No |
Coronary artery injury | No | Possible | + (spasm with pentaspline) |
Hemolysis | No | No | Possible |
Durability at 1 year | 60–73% | 70–90% | 70–90% |
*Vessels, nerves, esophagus
Abbreviations: CBA, cryoballoon ablation; FDA, Food and Drug Administration; GA, general anesthesia; PFA, pulsed-field ablation; PVI, pulmonary vein isolation; PVs, pulmonary veins; RFA, radiofrequency ablation.
. | Thermal energy . | Non-thermal energy . | |
---|---|---|---|
CBA . | RFA . | PFA . | |
Mechanism | Freezing | Heating | Electric current generation |
Characteristics | Thermal cell damage | Thermal cell damage | Non-thermal cell damage |
Tissue selectivity | Nonselective | Nonselective | Selective |
Catheters footprint | Balloon | Balloon & Point-by-point | Different footprints |
Time to ablation effect | Time-needed thermal effect | Time-needed thermal effect | Instant electroporation |
Patient preparation | Deep sedation or GA | Deep sedation or GA | Deep sedation or GA |
Fluoroscopy | Majority needed | Majority needed | Needed |
3-D mapping integration | No | Yes | With or without |
First pass PVI | > 98% | 98% | ~100% |
Ablation time | ++ | ++ | + |
Single-shot isolation | + | + | ++ |
Ablation beyond PVs | No | Yes | Possible |
Adjacent tissue damage* | Yes | Yes | No |
Pericardial injury | Rare | + | No |
Esophageal fistula | No | + | No |
Phrenic nerve palsy | + (usually transient) | Rare | No |
Coronary artery injury | No | Possible | + (spasm with pentaspline) |
Hemolysis | No | No | Possible |
Durability at 1 year | 60–73% | 70–90% | 70–90% |
. | Thermal energy . | Non-thermal energy . | |
---|---|---|---|
CBA . | RFA . | PFA . | |
Mechanism | Freezing | Heating | Electric current generation |
Characteristics | Thermal cell damage | Thermal cell damage | Non-thermal cell damage |
Tissue selectivity | Nonselective | Nonselective | Selective |
Catheters footprint | Balloon | Balloon & Point-by-point | Different footprints |
Time to ablation effect | Time-needed thermal effect | Time-needed thermal effect | Instant electroporation |
Patient preparation | Deep sedation or GA | Deep sedation or GA | Deep sedation or GA |
Fluoroscopy | Majority needed | Majority needed | Needed |
3-D mapping integration | No | Yes | With or without |
First pass PVI | > 98% | 98% | ~100% |
Ablation time | ++ | ++ | + |
Single-shot isolation | + | + | ++ |
Ablation beyond PVs | No | Yes | Possible |
Adjacent tissue damage* | Yes | Yes | No |
Pericardial injury | Rare | + | No |
Esophageal fistula | No | + | No |
Phrenic nerve palsy | + (usually transient) | Rare | No |
Coronary artery injury | No | Possible | + (spasm with pentaspline) |
Hemolysis | No | No | Possible |
Durability at 1 year | 60–73% | 70–90% | 70–90% |
*Vessels, nerves, esophagus
Abbreviations: CBA, cryoballoon ablation; FDA, Food and Drug Administration; GA, general anesthesia; PFA, pulsed-field ablation; PVI, pulmonary vein isolation; PVs, pulmonary veins; RFA, radiofrequency ablation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.